Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
magnesium + dexmedetomidine
- Development stage
- Approved
- Lead developer
- Istanbul University
- Modality
- Small Molecules
- Administration
- Oral, Intravenous
01
Overview
Magnesium + dexmedetomidine is a combination therapy approach investigated by researchers at Istanbul University for the management of hemodynamic instability during laparoscopic pheochromocytoma excision. The intervention involves pre-operative oral magnesium followed by intra-operative infusions of both magnesium and dexmedetomidine. Magnesium acts as a calcium antagonist, inhibiting the release of catecholamines from the adrenal medulla and nerve endings, and also functions as an alpha-adrenoreceptor antagonist. Dexmedetomidine is a highly selective alpha-2 adrenergic agonist that provides sympatholytic, sedative, and analgesic effects. This combination is designed to reduce the requirement for vasodilators like sodium nitroprusside and to stabilize blood pressure and heart rate during the surgical manipulation of catecholamine-secreting tumors.
- Other names
- Magnesium-DexmedetomidineMg-Dex
02
Targets
NeuraminidaseLTCC (Voltage-gated calcium channel (L-type))NaV (Voltage-gated sodium channels)ADRA2A (α2A)ADRA1 (Alpha-1 adrenergic receptor family)CaV (Voltage-gated calcium channel protein complex)
Beyond the preview
Go deeper on magnesium + dexmedetomidine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on magnesium + dexmedetomidine.